Teva in pre-emptive strike to protect proposed Byetta generic

21-01-2015

Teva in pre-emptive strike to protect proposed Byetta generic

patpitchaya / Shutterstock.com

Teva has filed for a declaratory judgment that it did not infringe patents belonging to AstraZeneca and Amylin Pharmaceuticals that protect diabetes drug Byetta (exenatide).


Teva, AstraZeneca, Amylin, Byetta, declaratory judgment

LSIPR